Ceres Pharmaceuticals
0407.326.754 · rovalta.com · 23/09/2026
ACTIVE
Ceres Pharmaceuticals
Financial year 2025 · closed on 31/12/2025
Net result
2,6 M €
+2759.4% YoY
Revenue
14,6 M €
+17.1% YoY
Equity
1,3 M €
-50.8% YoY
Workforce
17,6 ETP
-26.4% YoY
Overview
What does Ceres Pharmaceuticals do?
Ceres Pharmaceuticals is a Public limited company incorporated in 1970. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Gent. It employs on average 17,6 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0407.326.754
Incorporation
23/09/1970
Legal form
Public limited company
Registered office
Kortrijksesteenweg 1091 box B
9051 Gent · FlandreSee on map
9051 Gent · FlandreSee on map
Contributed capital
1 000 000,00 €
Latest accounts
31/12/2025
Average workforce
17,6 ETP
Activities (NACE)
Joint committees (4)
- 100
- 200
- 207
- 218
Signals
ProfitableLow riskPositive cashflowPositive EBITDAHealthy social debtsHigh revenue
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||||||
| Revenue | 14,6 M € | +17.1% | 12,5 M € | +17.4% | 10,6 M € | -2.8% | 10,9 M € | +7.2% | 10,2 M € | +21.9% | 8,3 M € | -0.7% | 8,4 M € | -4.7% | 8,8 M € | +4.0% | 8,5 M € | +1.5% | 8,4 M € | +0.6% | 8,3 M € | +6.1% | 7,8 M € | +4.9% | 7,5 M € | -0.8% | 7,5 M € | +5.6% | 7,1 M € | +8.3% | 6,6 M € | -4.0% | 6,9 M € | +12.3% | 6,1 M € | +13.9% | 5,4 M € | -7.9% | 5,8 M € |
| EBITDA | 3,5 M € | +6800% | -52,7 k € | +79.4% | -255,8 k € | -150% | 507,6 k € | -47.7% | 970,9 k € | +12.3% | 864,6 k € | +9.8% | 787,3 k € | -13.8% | 913 k € | +40.3% | 650,7 k € | -12.1% | 740,6 k € | +3.7% | 714,5 k € | +28.1% | 557,6 k € | +7.9% | 517 k € | -27.0% | 708 k € | +104% | 347,6 k € | -8.4% | 379,5 k € | -51.1% | 775,7 k € | +31.0% | 592,3 k € | +172% | 217,9 k € | -43.9% | 388,2 k € |
| Operating result | 3,6 M € | +4896% | -74,8 k € | +75.9% | -310,5 k € | -170% | 444,4 k € | -50.7% | 901,6 k € | +12.1% | 804,2 k € | +11.9% | 718,6 k € | -3.9% | 748,1 k € | +124% | 334,1 k € | -42.5% | 581,6 k € | -10.2% | 648 k € | +40.9% | 459,9 k € | +77.4% | 259,2 k € | -53.2% | 553,8 k € | +131% | 239,8 k € | -21.0% | 303,5 k € | -58.3% | 727,4 k € | +32.2% | 550,4 k € | +189% | 190,3 k € | -47.6% | 363,3 k € |
| Net result | 2,6 M € | +2759% | -99,2 k € | +67.0% | -300,4 k € | -208% | 278,4 k € | -56.8% | 644,8 k € | +10.1% | 585,6 k € | +20.2% | 487 k € | +21.0% | 402,6 k € | +130% | 175 k € | -49.0% | 343,4 k € | -12.0% | 390,3 k € | +40.6% | 277,6 k € | +599% | 39,7 k € | -87.0% | 305 k € | +177% | 110,2 k € | -34.2% | 167,3 k € | -63.8% | 462,5 k € | +32.1% | 350,2 k € | +1484% | 22,1 k € | -87.4% | 174,9 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||||||
| Equity | 1,3 M € | -50.8% | 2,7 M € | -3.6% | 2,8 M € | -9.7% | 3,1 M € | +9.9% | 2,8 M € | +29.9% | 2,2 M € | -18.0% | 2,6 M € | +22.7% | 2,1 M € | +23.1% | 1,7 M € | +11.2% | 1,6 M € | -6.4% | 1,7 M € | +7.3% | 1,6 M € | +21.6% | 1,3 M € | +3.2% | 1,2 M € | +15.5% | 1,1 M € | +0.6% | 1,1 M € | +0.8% | 1,1 M € | +0.2% | 1,1 M € | +0.0% | 1,1 M € | -15.5% | 1,3 M € |
| Total assets | 9,5 M € | +100% | 4,7 M € | +1.9% | 4,6 M € | +0.1% | 4,6 M € | +2.3% | 4,5 M € | -1.0% | 4,6 M € | +7.1% | 4,3 M € | +15.2% | 3,7 M € | -8.2% | 4 M € | -8.3% | 4,4 M € | +16.4% | 3,8 M € | +4.5% | 3,6 M € | +11.0% | 3,3 M € | -16.5% | 3,9 M € | +6.9% | 3,7 M € | +0.5% | 3,6 M € | -6.4% | 3,9 M € | +3.2% | 3,8 M € | +11.1% | 3,4 M € | -28.7% | 4,8 M € |
| Cash | 39,4 k € | -96.6% | 1,2 M € | +333% | 268,9 k € | -41.7% | 461,3 k € | -26.8% | 629,9 k € | +21.6% | 518,1 k € | +18.9% | 435,8 k € | -21.7% | 556,9 k € | +46.2% | 380,8 k € | +15.7% | 329,2 k € | -61.9% | 864,1 k € | +13.0% | 764,5 k € | +14.7% | 666,3 k € | -7.4% | 719,5 k € | +20.6% | 596,7 k € | +94.5% | 306,7 k € | -18.9% | 378,4 k € | -2.9% | 389,6 k € | +53.2% | 254,3 k € | -17.4% | 308 k € |
| Debts | 8 M € | +332% | 1,9 M € | +10.1% | 1,7 M € | +12.2% | 1,5 M € | -12.4% | 1,7 M € | -29.0% | 2,4 M € | +54.5% | 1,6 M € | +7.5% | 1,4 M € | -30.2% | 2,1 M € | -18.6% | 2,6 M € | +43.1% | 1,8 M € | +6.6% | 1,7 M € | -7.3% | 1,8 M € | -28.2% | 2,5 M € | +3.9% | 2,4 M € | -1.0% | 2,4 M € | -8.9% | 2,7 M € | +4.9% | 2,6 M € | +17.8% | 2,2 M € | -35.7% | 3,4 M € |
| Other | |||||||||||||||||||||||||||||||||||||||
| Workforce | 17,6 ETP | -26.4% | 23,9 ETP | -1.6% | 24,3 ETP | +3.8% | 23,4 ETP | +24.5% | 18,8 ETP | +22.9% | 15,3 ETP | -8.4% | 16,7 ETP | -20.1% | 20,9 ETP | -4.6% | 21,9 ETP | +2.3% | 21,4 ETP | 0.0% | 21,4 ETP | -2.3% | 21,9 ETP | -0.9% | 22,1 ETP | +1.4% | 21,8 ETP | +7.4% | 20,3 ETP | +2.0% | 19,9 ETP | +5.9% | 18,8 ETP | -6.0% | 20,0 ETP | -0.5% | 20,1 ETP | +4.1% | 19,3 ETP |
Estimate
Indicative valuation
As an indication, this company is worth
between 10 M€ and 25 M€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 2 active · 33 ended
Active mandates
Active
Active
Ended mandates
At this address
Other companies at this address
| Company | CBE no. |
|---|---|
2PHARMA● Active | 0886.662.746 |
2PHARMA HOLDING● Active | 0644.751.377 |
b+pharma Belgium● Active | 0474.817.869 |
BTW-eenheid Ter Beke● Active | 0893.541.630 |
Ceres Invest● Active | 0775.683.264 |
Ceres Pharma● Active | 0641.953.324 |
CONESSENCE● Active | 0819.266.552 |
Conessence Engineering● Active | 0794.812.555 |
CONESSENCE FINANCIAL RECRUITMENT● Active | 0681.915.443 |
CREDOPHAR● Active | 0849.730.193 |
DGPharma● Active | 0508.925.544 |
DRIEPUNTNUL● Active | 1021.711.292 |
HR ESSENTIALS● Active | 0721.702.467 |
KOUTERLOS● Active | 0450.036.349 |
Labophar● Active | 0643.723.177 |
MD Pharma● Active | 0667.779.672 |
PADEL FACTORY● Active | 0801.951.260 |
| 0865.651.952 | |
What’s Cooking Belgium● Active | 0884.649.304 |
What's Cooking Group● Active | 0421.364.139 |
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 22/07/2026 | 30/07/2025 | 03/07/2024 | 18/07/2023 | 20/07/2022 | 19/07/2021 |
| General meeting | 30/06/2026 | 10/06/2025 | 11/06/2024 | 20/06/2023 | 24/06/2022 | 25/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
20 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 30/06/2026 | 22/07/2026 | Dutch | |
| Full model | 31/12/2024 | 10/06/2025 | 30/07/2025 | Dutch | |
| Full model | 31/12/2023 | 11/06/2024 | 03/07/2024 | Dutch | |
| Full model | 31/12/2022 | 20/06/2023 | 18/07/2023 | Dutch | |
| Full model | 31/12/2021 | 24/06/2022 | 20/07/2022 | Dutch | |
| Full model | 31/12/2020 | 25/06/2021 | 19/07/2021 | Dutch | |
| Full model | 31/12/2019 | 29/06/2020 | 02/07/2020 | Dutch | |
| Full model | 31/12/2018 | 14/05/2019 | 04/07/2019 | Dutch | |
| Full model | 31/12/2017 | 08/05/2018 | 08/06/2018 | Dutch | |
| Full model | 31/12/2016 | 09/05/2017 | 07/06/2017 | Dutch | |
| Full model | 31/12/2015 | 10/05/2016 | 17/06/2016 | Dutch | |
| Full model | 31/12/2014 | 12/05/2015 | 29/05/2015 | Dutch | |
| Full model | 31/12/2013 | 03/06/2014 | 19/06/2014 | Dutch | |
| Full model | 31/12/2012 | 04/06/2013 | 05/07/2013 | Dutch | |
| Full model | 31/12/2011 | 08/05/2012 | 25/07/2012 | Dutch | |
| Full model | 31/12/2010 | 10/05/2011 | 01/06/2011 | Dutch | |
| Full model | 31/12/2009 | 01/06/2010 | 25/06/2010 | Dutch | |
| Full model | 31/12/2008 | 12/05/2009 | 10/06/2009 | Dutch | |
| Full model | 31/12/2007 | 13/05/2008 | 29/05/2008 | Dutch | |
| Full model | 31/12/2006 | 29/05/2007 | 26/07/2007 | Dutch |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 10 M€ and 25 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 2 active · 33 ended
Active mandates
Active
Active
Ended mandates
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Mandates10/03/2026ONTSLAGEN - BENOEMINGEN
- Other12/05/2025BENAMING
- Mandates24/01/2025MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
- Mandates15/05/2024ONTSLAGEN - BENOEMINGEN
- Mandates12/01/2024BENAMING - DOEL - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - DIVERSEN
- Mandates19/05/2023ONTSLAGEN - BENOEMINGEN
- Registered office08/07/2021MAATSCHAPPELIJKE ZETEL
- Mandates27/04/2021ONTSLAGEN - BENOEMINGEN
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20252,6 M €↑
- 2024Annual accounts 2024-99,2 k €↑
- 2024Name changeCERES PHARMACEUTICALS
- 2023Annual accounts 2023-300,4 k €↓
- 2022Annual accounts 2022278,4 k €↓
- 2021Annual accounts 2021644,8 k €↑
- 2021Name changeKELA PHARMA
- 2020Annual accounts 2020585,6 k €↑
- 2019Annual accounts 2019487 k €↑
- 2018Annual accounts 2018402,6 k €↑
- 2017Annual accounts 2017175 k €↓
- 2016Annual accounts 2016343,4 k €↓
- 2015Annual accounts 2015390,3 k €↑
- 2014Annual accounts 2014277,6 k €↑
- 2013Annual accounts 201339,7 k €↓
- 2012Annual accounts 2012305 k €↑
- 2011Annual accounts 2011110,2 k €↓
- 2010Annual accounts 2010167,3 k €↓
- 2009Annual accounts 2009462,5 k €↑
- 2008Annual accounts 2008350,2 k €↑
- 2007Annual accounts 200722,1 k €↓
- 2006Annual accounts 2006174,9 k €
- 23/09/1970IncorporationPublic limited company